ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Clinical Practice Session

Should Disease Names Change to Reflect Genotype, Pathology, or Phenotype, and What Do Patients Think?

November 05, 2022 | 02:00 PM - 04:00 PM

Location: W320 Chapin, Orange County Convention Center‚ West Building

Session Description

This session reviews the issues around disease naming. Discussions include how changing the approach to names can reflect improved understanding of clinical phenotypes based on genetic, pathology, and other descriptors.

Support is provided by an educational grant from Travere Therapeutics, Inc.

Learning Objective(s)

  • Explain the limitations of current disease naming
  • Describe reasons to change naming methods, using FSGS as an example
  • Specify alternatives to the use of eponymous and pathological terms for disease naming

Learning Pathway(s)

  • Glomerular Diseases
  • Genetic Diseases and Development


  • Rasheed A. Gbadegesin, MBBS, MD, FASN
  • Catherine Quinlan, MD


  • Defining the Molecular Basis of Glomerular Disease
    02:00 PM - 02:30 PM
    Matthias Kretzler, MD
  • Change the Name: Genetics-Focused Naming
    02:30 PM - 03:00 PM
    Alicia B Byrne, PhD
  • Retain the Name: Pathology-Focused Naming
    03:00 PM - 03:30 PM
    Astrid Weins, MD, PhD, FASN
  • Patient Perspective: Implications of Naming for Alport Syndrome
    03:30 PM - 04:00 PM
    Susie Gear